4//SEC Filing
Foster Paul A 4
Accession 0001209191-18-051472
CIK 0001326732other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:28 PM ET
Size
8.8 KB
Accession
0001209191-18-051472
Insider Transaction Report
Form 4
Xencor IncXNCR
Foster Paul A
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2018-09-17$11.05/sh+40,000$442,000→ 44,952 total - Sale
Common Stock
2018-09-17$46.03/sh−40,000$1,841,208→ 4,952 total - Exercise/Conversion
Stock Option (right to buy)
2018-09-17−40,000→ 10,000 totalExercise: $11.05Exp: 2024-02-20→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 17, 2018.
- [F2]The weighted average sale price for the transaction reported was $46.0302, and the range of prices were between $46.0121 and $46.0782. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F3]The stock option is fully vested.
Documents
Issuer
Xencor Inc
CIK 0001326732
Entity typeother
Related Parties
1- filerCIK 0001591213
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 4:28 PM ET
- Size
- 8.8 KB